TRIM37 controls cancer-specific vulnerability to PLK4 inhibition

Franz Meitinger(Okinawa Institute of Science and Technology Graduate University), Karen Oegema(University of California San Diego)
Nature
September 9, 2020
Cited by 155


Related Papers